Literature DB >> 20952017

The delivery of prostate cancer care in the United States: implications for delivery system reform.

Ted A Skolarus1, David C Miller, Yun Zhang, John M Hollingsworth, Brent K Hollenbeck.   

Abstract

PURPOSE: Since health care in the United States is fragmented and expensive, 1 reform option focuses on improving care coordination as in the medical home model. To better understand care coordination in the context of prostate cancer we examined how the delivery of prostate cancer care is partitioned across primary care providers and specialists.
MATERIALS AND METHODS: We identified 105,961 patients diagnosed with prostate cancer between 1992 and 2005 using Surveillance, Epidemiology and End Results-Medicare data. We assigned all health care for prostate cancer and nonprostate cancer diagnoses by provider specialty across 3 distinct phases of care, including initial, continuing care and end of life. We then identified service types and proportions of care across specialties.
RESULTS: Urologists provided most prostate cancer care (45.2%). Radiation oncologist involvement decreased from 27.4% of claims in the initial phase to 5.5% and 5.7% in the continuing care and end of life phases, respectively. Conversely medical oncology and to a lesser degree primary care captured a greater percent of ongoing prostate cancer care. In patients with prostate cancer 7,120,343 of 36,837,904 services (19.3%) were directly related to prostate cancer care. Primary care providers were responsible for 47% of overall health care in men with prostate cancer.
CONCLUSIONS: Urologists provided most prostate cancer care while primary care providers were responsible for most overall health care in men with prostate cancer. In light of current reforms directed at improving care coordination urologists serve as a logical starting point to improve care delivery in the broader context of a medical home.
Copyright © 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20952017     DOI: 10.1016/j.juro.2010.08.002

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Understanding fragmentation of prostate cancer survivorship care: implications for cost and quality.

Authors:  Ted A Skolarus; Yun Zhang; Brent K Hollenbeck
Journal:  Cancer       Date:  2011-10-05       Impact factor: 6.860

2.  Non-oncologist Physician Knowledge of Radiation Therapy at an Urban Community Hospital.

Authors:  Evan Siau; Hernando Salazar; Jonathan Livergant; Jonathan Klein
Journal:  J Cancer Educ       Date:  2021-02       Impact factor: 2.037

3.  Prostate cancer survivorship care in the Veterans Health Administration.

Authors:  Ted A Skolarus; Sarah T Hawley
Journal:  Fed Pract       Date:  2014-08

4.  Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial.

Authors:  Ted A Skolarus; Tabitha Metreger; Soohyun Hwang; Hyungjin Myra Kim; Robert L Grubb; Jeffrey R Gingrich; Sarah T Hawley
Journal:  Trials       Date:  2017-04-18       Impact factor: 2.279

5.  Determinants of quality prostate cancer survivorship care across the primary and specialty care interface: Lessons from the Veterans Health Administration.

Authors:  Archana Radhakrishnan; Jennifer Henry; Kevin Zhu; Sarah T Hawley; Brent K Hollenbeck; Timothy Hofer; Daniela A Wittmann; Anne E Sales; Ted A Skolarus
Journal:  Cancer Med       Date:  2019-04-05       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.